#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=4 .
1-1	0-1	4	quantity	new	_	_
1-2	2-3	.	_	_	_	_

#Text=Patient Assessment
2-1	4-11	Patient	person|abstract[3]	new|new[3]	coref|coref	6-10|6-10
2-2	12-22	Assessment	abstract[3]	new[3]	_	_

#Text=Patients with PE may be uncomfortable discussing their ejaculatory disorder and as such may avoid seeking treatment .
3-1	23-31	Patients	person[4]	new[4]	ana	3-8[0_4]
3-2	32-36	with	person[4]	new[4]	_	_
3-3	37-39	PE	person[4]|abstract	new[4]|new	coref	16-9
3-4	40-43	may	_	_	_	_
3-5	44-46	be	_	_	_	_
3-6	47-60	uncomfortable	_	_	_	_
3-7	61-71	discussing	_	_	_	_
3-8	72-77	their	person|abstract[8]	giv|new[8]	coref|coref	5-18|5-18
3-9	78-89	ejaculatory	abstract|abstract[8]	new|new[8]	coref	17-5
3-10	90-98	disorder	abstract[8]	new[8]	_	_
3-11	99-102	and	_	_	_	_
3-12	103-105	as	_	_	_	_
3-13	106-110	such	_	_	_	_
3-14	111-114	may	_	_	_	_
3-15	115-120	avoid	_	_	_	_
3-16	121-128	seeking	_	_	_	_
3-17	129-138	treatment	abstract	new	coref	13-9
3-18	139-140	.	_	_	_	_

#Text=It is therefore important that clinicians establish sexual health as a routine topic during consultations .
4-1	141-143	It	abstract	new	cata	4-1[0_12]
4-2	144-146	is	_	_	_	_
4-3	147-156	therefore	_	_	_	_
4-4	157-166	important	_	_	_	_
4-5	167-171	that	abstract[12]	new[12]	_	_
4-6	172-182	clinicians	person|abstract[12]	new|new[12]	coref	20-4
4-7	183-192	establish	abstract[12]	new[12]	_	_
4-8	193-199	sexual	abstract[12]|abstract[13]	new[12]|new[13]	coref	5-9[17_13]
4-9	200-206	health	abstract[12]|abstract[13]	new[12]|new[13]	_	_
4-10	207-209	as	_	_	_	_
4-11	210-211	a	_	_	_	_
4-12	212-219	routine	_	_	_	_
4-13	220-225	topic	_	_	_	_
4-14	226-232	during	_	_	_	_
4-15	233-246	consultations	event	new	_	_
4-16	247-248	.	_	_	_	_

#Text=One common approach of initiating the conversation about sexual health , and to determine intervention levels for patients , is the PLISSIT Model , first introduced by Annon .
5-1	249-252	One	abstract[15]	new[15]	coref	5-21[22_15]
5-2	253-259	common	abstract[15]	new[15]	_	_
5-3	260-268	approach	abstract[15]	new[15]	_	_
5-4	269-271	of	_	_	_	_
5-5	272-282	initiating	_	_	_	_
5-6	283-286	the	abstract[16]	new[16]	coref	8-19[43_16]
5-7	287-299	conversation	abstract[16]	new[16]	_	_
5-8	300-305	about	abstract[16]	new[16]	_	_
5-9	306-312	sexual	abstract[16]|abstract[17]	new[16]|giv[17]	coref	7-26[37_17]
5-10	313-319	health	abstract[16]|abstract[17]	new[16]|giv[17]	_	_
5-11	320-321	,	_	_	_	_
5-12	322-325	and	_	_	_	_
5-13	326-328	to	_	_	_	_
5-14	329-338	determine	_	_	_	_
5-15	339-351	intervention	event|abstract[19]	new|new[19]	coref|coref	6-9[27_19]|6-9[27_19]
5-16	352-358	levels	abstract[19]	new[19]	_	_
5-17	359-362	for	abstract[19]	new[19]	_	_
5-18	363-371	patients	abstract[19]|person	new[19]|giv	ana	7-26
5-19	372-373	,	_	_	_	_
5-20	374-376	is	_	_	_	_
5-21	377-380	the	abstract[22]	giv[22]	coref	6-1[24_22]
5-22	381-388	PLISSIT	object|abstract[22]	new|giv[22]	_	_
5-23	389-394	Model	abstract[22]	giv[22]	_	_
5-24	395-396	,	_	_	_	_
5-25	397-402	first	_	_	_	_
5-26	403-413	introduced	_	_	_	_
5-27	414-416	by	_	_	_	_
5-28	417-422	Annon	person	new	_	_
5-29	423-424	.	_	_	_	_

#Text=This model is a stage-wise approach , and individual patient levels should be identified by the clinician .
6-1	425-429	This	abstract[24]	giv[24]	coref	6-4[25_24]
6-2	430-435	model	abstract[24]	giv[24]	_	_
6-3	436-438	is	_	_	_	_
6-4	439-440	a	abstract[25]	giv[25]	ana	7-3[0_25]
6-5	441-451	stage-wise	abstract[25]	giv[25]	_	_
6-6	452-460	approach	abstract[25]	giv[25]	_	_
6-7	461-462	,	_	_	_	_
6-8	463-466	and	_	_	_	_
6-9	467-477	individual	abstract[27]	giv[27]	_	_
6-10	478-485	patient	person|abstract[27]	giv|giv[27]	coref	9-8[46_0]
6-11	486-492	levels	abstract[27]	giv[27]	_	_
6-12	493-499	should	_	_	_	_
6-13	500-502	be	_	_	_	_
6-14	503-513	identified	_	_	_	_
6-15	514-516	by	_	_	_	_
6-16	517-520	the	person[28]	new[28]	coref	7-10[32_28]
6-17	521-530	clinician	person[28]	new[28]	_	_
6-18	531-532	.	_	_	_	_

#Text=Permission : This is the first stage in which the clinician gives the client permission to feel comfortable about and discuss a particular facet of their sexual health .
7-1	533-543	Permission	abstract	new	coref	7-13[34_0]
7-2	544-545	:	_	_	_	_
7-3	546-550	This	abstract	giv	coref	7-5[31_0]
7-4	551-553	is	_	_	_	_
7-5	554-557	the	abstract[31]	giv[31]	coref	9-5[45_31]
7-6	558-563	first	abstract[31]	giv[31]	_	_
7-7	564-569	stage	abstract[31]	giv[31]	_	_
7-8	570-572	in	_	_	_	_
7-9	573-578	which	_	_	_	_
7-10	579-582	the	person[32]	giv[32]	coref	8-4[39_32]
7-11	583-592	clinician	person[32]	giv[32]	_	_
7-12	593-598	gives	_	_	_	_
7-13	599-602	the	abstract[34]	giv[34]	_	_
7-14	603-609	client	person|abstract[34]	new|giv[34]	_	_
7-15	610-620	permission	abstract[34]	giv[34]	_	_
7-16	621-623	to	_	_	_	_
7-17	624-628	feel	_	_	_	_
7-18	629-640	comfortable	_	_	_	_
7-19	641-646	about	_	_	_	_
7-20	647-650	and	_	_	_	_
7-21	651-658	discuss	_	_	_	_
7-22	659-660	a	abstract[35]	new[35]	_	_
7-23	661-671	particular	abstract[35]	new[35]	_	_
7-24	672-677	facet	abstract[35]	new[35]	_	_
7-25	678-680	of	abstract[35]	new[35]	_	_
7-26	681-686	their	abstract[35]|person|abstract[37]	new[35]|giv|giv[37]	coref|coref|coref|coref	10-20[59_37]|11-9|10-20[59_37]|11-9
7-27	687-693	sexual	abstract[35]|abstract[37]	new[35]|giv[37]	_	_
7-28	694-700	health	abstract[35]|abstract[37]	new[35]|giv[37]	_	_
7-29	701-702	.	_	_	_	_

#Text=It is imperative the clinician maintains a professional , non-judgmental attitude during this time in order to facilitate the conversation .
8-1	703-705	It	place	new	cata	8-1[0_40]
8-2	706-708	is	_	_	_	_
8-3	709-719	imperative	_	_	_	_
8-4	720-723	the	person[39]	giv[39]	coref	10-8[53_39]
8-5	724-733	clinician	person[39]	giv[39]	_	_
8-6	734-743	maintains	place[40]	new[40]	_	_
8-7	744-745	a	place[40]|abstract[41]	new[40]|new[41]	_	_
8-8	746-758	professional	place[40]|abstract[41]	new[40]|new[41]	_	_
8-9	759-760	,	place[40]|abstract[41]	new[40]|new[41]	_	_
8-10	761-775	non-judgmental	place[40]|abstract[41]	new[40]|new[41]	_	_
8-11	776-784	attitude	place[40]|abstract[41]	new[40]|new[41]	_	_
8-12	785-791	during	_	_	_	_
8-13	792-796	this	time[42]	new[42]	_	_
8-14	797-801	time	time[42]	new[42]	_	_
8-15	802-804	in	_	_	_	_
8-16	805-810	order	_	_	_	_
8-17	811-813	to	_	_	_	_
8-18	814-824	facilitate	_	_	_	_
8-19	825-828	the	abstract[43]	giv[43]	_	_
8-20	829-841	conversation	abstract[43]	giv[43]	_	_
8-21	842-843	.	_	_	_	_

#Text=Limited Information : In this stage , the patient is provided with limited information about a topic or issue .
9-1	844-851	Limited	abstract[44]	new[44]	_	_
9-2	852-863	Information	abstract[44]	new[44]	_	_
9-3	864-865	:	_	_	_	_
9-4	866-868	In	_	_	_	_
9-5	869-873	this	abstract[45]	giv[45]	coref	10-5[52_45]
9-6	874-879	stage	abstract[45]	giv[45]	_	_
9-7	880-881	,	_	_	_	_
9-8	882-885	the	person[46]	giv[46]	coref	10-15[0_46]
9-9	886-893	patient	person[46]	giv[46]	_	_
9-10	894-896	is	_	_	_	_
9-11	897-905	provided	_	_	_	_
9-12	906-910	with	_	_	_	_
9-13	911-918	limited	abstract[47]	new[47]	coref	10-25[0_47]
9-14	919-930	information	abstract[47]	new[47]	_	_
9-15	931-936	about	abstract[47]	new[47]	_	_
9-16	937-938	a	abstract[47]|abstract[48]|abstract[49]	new[47]|new[48]|new[49]	ana|coref|ana|coref	10-20[0_49]|12-9[72_48]|10-20[0_49]|12-9[72_48]
9-17	939-944	topic	abstract[47]|abstract[48]|abstract[49]	new[47]|new[48]|new[49]	_	_
9-18	945-947	or	abstract[47]|abstract[49]	new[47]|new[49]	_	_
9-19	948-953	issue	abstract[47]|abstract[49]|abstract	new[47]|new[49]|new	coref	14-20[84_0]
9-20	954-955	.	_	_	_	_

#Text=It is important in this stage that the clinician learns about specific topics the patient wishes to discuss surrounding their sexual health and provide information for the specific subject .
10-1	956-958	It	place	new	cata	10-1[0_54]
10-2	959-961	is	_	_	_	_
10-3	962-971	important	_	_	_	_
10-4	972-974	in	_	_	_	_
10-5	975-979	this	abstract[52]	giv[52]	_	_
10-6	980-985	stage	abstract[52]	giv[52]	_	_
10-7	986-990	that	place[54]	new[54]	ana	12-1[0_54]
10-8	991-994	the	person[53]|place[54]	giv[53]|new[54]	coref	11-6[63_53]
10-9	995-1004	clinician	person[53]|place[54]	giv[53]|new[54]	_	_
10-10	1005-1011	learns	place[54]	new[54]	_	_
10-11	1012-1017	about	place[54]	new[54]	_	_
10-12	1018-1026	specific	place[54]|abstract[55]	new[54]|new[55]	coref	11-14[66_55]
10-13	1027-1033	topics	place[54]|abstract[55]	new[54]|new[55]	_	_
10-14	1034-1037	the	place[54]|abstract[57]	new[54]|new[57]	_	_
10-15	1038-1045	patient	place[54]|person|abstract[57]	new[54]|giv|new[57]	coref	11-19[67_0]
10-16	1046-1052	wishes	place[54]|abstract[57]	new[54]|new[57]	_	_
10-17	1053-1055	to	place[54]	new[54]	_	_
10-18	1056-1063	discuss	place[54]	new[54]	_	_
10-19	1064-1075	surrounding	place[54]	new[54]	_	_
10-20	1076-1081	their	place[54]|abstract|abstract[59]	new[54]|giv|giv[59]	coref|coref	11-18[68_59]|11-18[68_59]
10-21	1082-1088	sexual	place[54]|abstract[59]	new[54]|giv[59]	_	_
10-22	1089-1095	health	place[54]|abstract[59]	new[54]|giv[59]	_	_
10-23	1096-1099	and	place[54]	new[54]	_	_
10-24	1100-1107	provide	place[54]	new[54]	_	_
10-25	1108-1119	information	place[54]|abstract	new[54]|giv	coref	13-1
10-26	1120-1123	for	_	_	_	_
10-27	1124-1127	the	abstract[61]	new[61]	_	_
10-28	1128-1136	specific	abstract[61]	new[61]	_	_
10-29	1137-1144	subject	abstract[61]	new[61]	_	_
10-30	1145-1146	.	_	_	_	_

#Text=Specific Suggestion : Here , the clinician provides patients with specific advice on particular topics relating to the patient ’s sexual health .
11-1	1147-1155	Specific	abstract[62]	new[62]	_	_
11-2	1156-1166	Suggestion	abstract[62]	new[62]	_	_
11-3	1167-1168	:	_	_	_	_
11-4	1169-1173	Here	_	_	_	_
11-5	1174-1175	,	_	_	_	_
11-6	1176-1179	the	person[63]	giv[63]	coref	29-25[179_63]
11-7	1180-1189	clinician	person[63]	giv[63]	_	_
11-8	1190-1198	provides	_	_	_	_
11-9	1199-1207	patients	person	giv	coref	17-9
11-10	1208-1212	with	_	_	_	_
11-11	1213-1221	specific	abstract[65]	new[65]	_	_
11-12	1222-1228	advice	abstract[65]	new[65]	_	_
11-13	1229-1231	on	abstract[65]	new[65]	_	_
11-14	1232-1242	particular	abstract[65]|abstract[66]	new[65]|giv[66]	_	_
11-15	1243-1249	topics	abstract[65]|abstract[66]	new[65]|giv[66]	_	_
11-16	1250-1258	relating	_	_	_	_
11-17	1259-1261	to	_	_	_	_
11-18	1262-1265	the	abstract[68]	giv[68]	coref	14-29[87_68]
11-19	1266-1273	patient	person[67]|abstract[68]	giv[67]|giv[68]	coref	12-6[0_67]
11-20	1274-1276	’s	person[67]|abstract[68]	giv[67]|giv[68]	_	_
11-21	1277-1283	sexual	abstract[68]	giv[68]	_	_
11-22	1284-1290	health	abstract[68]	giv[68]	_	_
11-23	1291-1292	.	_	_	_	_

#Text=This is completed after full patient evaluation surrounding the topic .
12-1	1293-1297	This	place	giv	_	_
12-2	1298-1300	is	_	_	_	_
12-3	1301-1310	completed	_	_	_	_
12-4	1311-1316	after	_	_	_	_
12-5	1317-1321	full	abstract[71]	new[71]	coref	27-7[161_71]
12-6	1322-1329	patient	person|abstract[71]	giv|new[71]	coref	14-11[82_0]
12-7	1330-1340	evaluation	abstract[71]	new[71]	_	_
12-8	1341-1352	surrounding	_	_	_	_
12-9	1353-1356	the	abstract[72]	giv[72]	_	_
12-10	1357-1362	topic	abstract[72]	giv[72]	_	_
12-11	1363-1364	.	_	_	_	_

#Text=Information includes suggested behavioural changes as well as treatment options for a specific concern .
13-1	1365-1376	Information	abstract	giv	_	_
13-2	1377-1385	includes	_	_	_	_
13-3	1386-1395	suggested	abstract[74]|abstract[75]	new[74]|new[75]	ana|ana	14-29[0_75]|14-29[0_75]
13-4	1396-1407	behavioural	abstract[74]|abstract[75]	new[74]|new[75]	_	_
13-5	1408-1415	changes	abstract[74]|abstract[75]	new[74]|new[75]	_	_
13-6	1416-1418	as	abstract[75]	new[75]	_	_
13-7	1419-1423	well	abstract[75]	new[75]	_	_
13-8	1424-1426	as	abstract[75]	new[75]	_	_
13-9	1427-1436	treatment	abstract[75]|abstract|abstract[77]	new[75]|giv|new[77]	coref|coref	15-9[91_0]|15-9[91_0]
13-10	1437-1444	options	abstract[75]|abstract[77]	new[75]|new[77]	_	_
13-11	1445-1448	for	abstract[75]|abstract[77]	new[75]|new[77]	_	_
13-12	1449-1450	a	abstract[75]|abstract[77]|abstract[78]	new[75]|new[77]|new[78]	ana	14-4[0_78]
13-13	1451-1459	specific	abstract[75]|abstract[77]|abstract[78]	new[75]|new[77]|new[78]	_	_
13-14	1460-1467	concern	abstract[75]|abstract[77]|abstract[78]	new[75]|new[77]|new[78]	_	_
13-15	1468-1469	.	_	_	_	_

#Text=Intensive Therapy : This is the last stage in which the patient begins psychological and/or pharmacological therapy to remediate a specific issue the patient is suffering from regarding their sexual health .
14-1	1470-1479	Intensive	abstract[79]	new[79]	_	_
14-2	1480-1487	Therapy	abstract[79]	new[79]	_	_
14-3	1488-1489	:	_	_	_	_
14-4	1490-1494	This	abstract	giv	coref	14-6[81_0]
14-5	1495-1497	is	_	_	_	_
14-6	1498-1501	the	abstract[81]	giv[81]	_	_
14-7	1502-1506	last	abstract[81]	giv[81]	_	_
14-8	1507-1512	stage	abstract[81]	giv[81]	_	_
14-9	1513-1515	in	_	_	_	_
14-10	1516-1521	which	_	_	_	_
14-11	1522-1525	the	person[82]	giv[82]	coref	14-23[85_82]
14-12	1526-1533	patient	person[82]	giv[82]	_	_
14-13	1534-1540	begins	_	_	_	_
14-14	1541-1554	psychological	event[83]	new[83]	coref	31-33[0_83]
14-15	1555-1561	and/or	event[83]	new[83]	_	_
14-16	1562-1577	pharmacological	event[83]	new[83]	_	_
14-17	1578-1585	therapy	event[83]	new[83]	_	_
14-18	1586-1588	to	_	_	_	_
14-19	1589-1598	remediate	_	_	_	_
14-20	1599-1600	a	abstract[84]	giv[84]	_	_
14-21	1601-1609	specific	abstract[84]	giv[84]	_	_
14-22	1610-1615	issue	abstract[84]	giv[84]	_	_
14-23	1616-1619	the	person[85]	giv[85]	coref	19-10[111_85]
14-24	1620-1627	patient	person[85]	giv[85]	_	_
14-25	1628-1630	is	_	_	_	_
14-26	1631-1640	suffering	_	_	_	_
14-27	1641-1645	from	_	_	_	_
14-28	1646-1655	regarding	_	_	_	_
14-29	1656-1661	their	abstract|abstract[87]	giv|giv[87]	ana|ana	15-1[0_87]|15-1[0_87]
14-30	1662-1668	sexual	abstract[87]	giv[87]	_	_
14-31	1669-1675	health	abstract[87]	giv[87]	_	_
14-32	1676-1677	.	_	_	_	_

#Text=This may include referral to a specialist for further treatment and management .
15-1	1678-1682	This	abstract	giv	_	_
15-2	1683-1686	may	_	_	_	_
15-3	1687-1694	include	_	_	_	_
15-4	1695-1703	referral	event	new	_	_
15-5	1704-1706	to	_	_	_	_
15-6	1707-1708	a	person[90]	new[90]	_	_
15-7	1709-1719	specialist	person[90]	new[90]	_	_
15-8	1720-1723	for	person[90]	new[90]	_	_
15-9	1724-1731	further	person[90]|abstract[91]	new[90]|giv[91]	coref	32-13[214_91]
15-10	1732-1741	treatment	person[90]|abstract[91]	new[90]|giv[91]	_	_
15-11	1742-1745	and	person[90]	new[90]	_	_
15-12	1746-1756	management	person[90]|organization	new[90]|new	_	_
15-13	1757-1758	.	_	_	_	_

#Text=As previously discussed , confirming a diagnosis of PE requires the presence of all three components .
16-1	1759-1761	As	_	_	_	_
16-2	1762-1772	previously	_	_	_	_
16-3	1773-1782	discussed	_	_	_	_
16-4	1783-1784	,	_	_	_	_
16-5	1785-1795	confirming	_	_	_	_
16-6	1796-1797	a	abstract[93]	new[93]	coref	23-22[140_93]
16-7	1798-1807	diagnosis	abstract[93]	new[93]	_	_
16-8	1808-1810	of	abstract[93]	new[93]	_	_
16-9	1811-1813	PE	abstract[93]|abstract	new[93]|giv	coref	20-33[120_0]
16-10	1814-1822	requires	_	_	_	_
16-11	1823-1826	the	abstract[95]	new[95]	_	_
16-12	1827-1835	presence	abstract[95]	new[95]	_	_
16-13	1836-1838	of	abstract[95]	new[95]	_	_
16-14	1839-1842	all	abstract[95]|abstract[96]	new[95]|new[96]	coref	28-14[172_96]
16-15	1843-1848	three	abstract[95]|abstract[96]	new[95]|new[96]	_	_
16-16	1849-1859	components	abstract[95]|abstract[96]	new[95]|new[96]	_	_
16-17	1860-1861	.	_	_	_	_

#Text=The first relates to ejaculatory latency , with patients having an IELT of one minute or less on all or nearly all sexual encounters , or a reduction in IELT to about three minutes .
17-1	1862-1865	The	_	_	_	_
17-2	1866-1871	first	_	_	_	_
17-3	1872-1879	relates	_	_	_	_
17-4	1880-1882	to	_	_	_	_
17-5	1883-1894	ejaculatory	place|event[98]	giv|new[98]	coref|coref|coref|coref	23-3|30-40[0_98]|23-3|30-40[0_98]
17-6	1895-1902	latency	event[98]	new[98]	_	_
17-7	1903-1904	,	_	_	_	_
17-8	1905-1909	with	_	_	_	_
17-9	1910-1918	patients	person	giv	coref	30-11[187_0]
17-10	1919-1925	having	_	_	_	_
17-11	1926-1928	an	abstract[100]	new[100]	coref	17-30[0_100]
17-12	1929-1933	IELT	abstract[100]	new[100]	_	_
17-13	1934-1936	of	abstract[100]	new[100]	_	_
17-14	1937-1940	one	abstract[100]|time[101]	new[100]|new[101]	_	_
17-15	1941-1947	minute	abstract[100]|time[101]	new[100]|new[101]	_	_
17-16	1948-1950	or	abstract[100]	new[100]	_	_
17-17	1951-1955	less	abstract[100]	new[100]	_	_
17-18	1956-1958	on	abstract[100]	new[100]	_	_
17-19	1959-1962	all	abstract[100]	new[100]	_	_
17-20	1963-1965	or	abstract[100]	new[100]	_	_
17-21	1966-1972	nearly	abstract[100]|event[102]	new[100]|new[102]	_	_
17-22	1973-1976	all	abstract[100]|event[102]	new[100]|new[102]	_	_
17-23	1977-1983	sexual	abstract[100]|event[102]	new[100]|new[102]	_	_
17-24	1984-1994	encounters	abstract[100]|event[102]	new[100]|new[102]	_	_
17-25	1995-1996	,	_	_	_	_
17-26	1997-1999	or	_	_	_	_
17-27	2000-2001	a	abstract[103]	new[103]	_	_
17-28	2002-2011	reduction	abstract[103]	new[103]	_	_
17-29	2012-2014	in	abstract[103]	new[103]	_	_
17-30	2015-2019	IELT	abstract[103]|abstract	new[103]|giv	coref	21-9
17-31	2020-2022	to	abstract[103]	new[103]	_	_
17-32	2023-2028	about	abstract[103]|time[105]	new[103]|new[105]	_	_
17-33	2029-2034	three	abstract[103]|time[105]	new[103]|new[105]	_	_
17-34	2035-2042	minutes	abstract[103]|time[105]	new[103]|new[105]	_	_
17-35	2043-2044	.	_	_	_	_

#Text=The second is a lack of control , or inability to delay ejaculation .
18-1	2045-2048	The	_	_	_	_
18-2	2049-2055	second	_	_	_	_
18-3	2056-2058	is	_	_	_	_
18-4	2059-2060	a	abstract[106]	new[106]	_	_
18-5	2061-2065	lack	abstract[106]	new[106]	_	_
18-6	2066-2068	of	abstract[106]	new[106]	_	_
18-7	2069-2076	control	abstract[106]|abstract	new[106]|new	coref	23-3[135_0]
18-8	2077-2078	,	_	_	_	_
18-9	2079-2081	or	_	_	_	_
18-10	2082-2091	inability	abstract	new	_	_
18-11	2092-2094	to	_	_	_	_
18-12	2095-2100	delay	_	_	_	_
18-13	2101-2112	ejaculation	abstract	new	coref	27-10[162_0]
18-14	2113-2114	.	_	_	_	_

#Text=Finally , there must be negative personal consequences for the patient , which may include psychological or interpersonal issues .
19-1	2115-2122	Finally	_	_	_	_
19-2	2123-2124	,	_	_	_	_
19-3	2125-2130	there	_	_	_	_
19-4	2131-2135	must	_	_	_	_
19-5	2136-2138	be	_	_	_	_
19-6	2139-2147	negative	abstract[110]	new[110]	_	_
19-7	2148-2156	personal	abstract[110]	new[110]	_	_
19-8	2157-2169	consequences	abstract[110]	new[110]	_	_
19-9	2170-2173	for	abstract[110]	new[110]	_	_
19-10	2174-2177	the	abstract[110]|person[111]	new[110]|giv[111]	coref	20-9[114_111]
19-11	2178-2185	patient	abstract[110]|person[111]	new[110]|giv[111]	_	_
19-12	2186-2187	,	_	_	_	_
19-13	2188-2193	which	_	_	_	_
19-14	2194-2197	may	_	_	_	_
19-15	2198-2205	include	_	_	_	_
19-16	2206-2219	psychological	abstract[112]	new[112]	_	_
19-17	2220-2222	or	abstract[112]	new[112]	_	_
19-18	2223-2236	interpersonal	abstract[112]	new[112]	_	_
19-19	2237-2243	issues	abstract[112]	new[112]	_	_
19-20	2244-2245	.	_	_	_	_

#Text=As such , clinicians must primarily explore the patient ’s sexual history ; however a full medical history , psychological history and a physical exam is often necessary to provide context surrounding the PE and to consider possible underlying causes of acquired PE .
20-1	2246-2248	As	_	_	_	_
20-2	2249-2253	such	_	_	_	_
20-3	2254-2255	,	_	_	_	_
20-4	2256-2266	clinicians	person	giv	_	_
20-5	2267-2271	must	_	_	_	_
20-6	2272-2281	primarily	_	_	_	_
20-7	2282-2289	explore	_	_	_	_
20-8	2290-2293	the	abstract[115]	new[115]	coref	20-14[116_115]
20-9	2294-2301	patient	person[114]|abstract[115]	giv[114]|new[115]	coref	23-10[0_114]
20-10	2302-2304	’s	person[114]|abstract[115]	giv[114]|new[115]	_	_
20-11	2305-2311	sexual	abstract[115]	new[115]	_	_
20-12	2312-2319	history	abstract[115]	new[115]	_	_
20-13	2320-2321	;	_	_	_	_
20-14	2322-2329	however	abstract[116]	giv[116]	coref	20-20[117_116]
20-15	2330-2331	a	abstract[116]	giv[116]	_	_
20-16	2332-2336	full	abstract[116]	giv[116]	_	_
20-17	2337-2344	medical	abstract[116]	giv[116]	_	_
20-18	2345-2352	history	abstract[116]	giv[116]	_	_
20-19	2353-2354	,	_	_	_	_
20-20	2355-2368	psychological	abstract[117]	giv[117]	coref	21-1[123_117]
20-21	2369-2376	history	abstract[117]	giv[117]	_	_
20-22	2377-2380	and	_	_	_	_
20-23	2381-2382	a	event[118]	new[118]	_	_
20-24	2383-2391	physical	event[118]	new[118]	_	_
20-25	2392-2396	exam	event[118]	new[118]	_	_
20-26	2397-2399	is	_	_	_	_
20-27	2400-2405	often	_	_	_	_
20-28	2406-2415	necessary	_	_	_	_
20-29	2416-2418	to	_	_	_	_
20-30	2419-2426	provide	_	_	_	_
20-31	2427-2434	context	abstract	new	_	_
20-32	2435-2446	surrounding	_	_	_	_
20-33	2447-2450	the	abstract[120]	giv[120]	coref	20-42[122_120]
20-34	2451-2453	PE	abstract[120]	giv[120]	_	_
20-35	2454-2457	and	_	_	_	_
20-36	2458-2460	to	_	_	_	_
20-37	2461-2469	consider	_	_	_	_
20-38	2470-2478	possible	_	_	_	_
20-39	2479-2489	underlying	abstract[121]	new[121]	_	_
20-40	2490-2496	causes	abstract[121]	new[121]	_	_
20-41	2497-2499	of	abstract[121]	new[121]	_	_
20-42	2500-2508	acquired	abstract[121]|abstract[122]	new[121]|giv[122]	coref	21-19[0_122]
20-43	2509-2511	PE	abstract[121]|abstract[122]	new[121]|giv[122]	_	_
20-44	2512-2513	.	_	_	_	_

#Text=The sexual history should involve an estimate of IELT , as well as the onset and duration of PE .
21-1	2514-2517	The	abstract[123]	giv[123]	coref	22-5[130_123]
21-2	2518-2524	sexual	abstract[123]	giv[123]	_	_
21-3	2525-2532	history	abstract[123]	giv[123]	_	_
21-4	2533-2539	should	_	_	_	_
21-5	2540-2547	involve	_	_	_	_
21-6	2548-2550	an	abstract[124]	new[124]	_	_
21-7	2551-2559	estimate	abstract[124]	new[124]	_	_
21-8	2560-2562	of	abstract[124]	new[124]	_	_
21-9	2563-2567	IELT	abstract[124]|abstract	new[124]|giv	coref	30-19
21-10	2568-2569	,	_	_	_	_
21-11	2570-2572	as	_	_	_	_
21-12	2573-2577	well	_	_	_	_
21-13	2578-2580	as	_	_	_	_
21-14	2581-2584	the	abstract[126]	new[126]	_	_
21-15	2585-2590	onset	abstract[126]	new[126]	_	_
21-16	2591-2594	and	_	_	_	_
21-17	2595-2603	duration	time[127]	new[127]	_	_
21-18	2604-2606	of	time[127]	new[127]	_	_
21-19	2607-2609	PE	time[127]|abstract	new[127]|giv	coref	22-18[132_0]
21-20	2610-2611	.	_	_	_	_

#Text=Previous sexual functioning and history of sexual relations are also necessary in order to delineate acquired and lifelong PE .
22-1	2612-2620	Previous	abstract[129]	new[129]	_	_
22-2	2621-2627	sexual	abstract[129]	new[129]	_	_
22-3	2628-2639	functioning	abstract[129]	new[129]	_	_
22-4	2640-2643	and	_	_	_	_
22-5	2644-2651	history	abstract[130]	giv[130]	coref	24-1[142_130]
22-6	2652-2654	of	abstract[130]	giv[130]	_	_
22-7	2655-2661	sexual	abstract[130]|event[131]	giv[130]|new[131]	_	_
22-8	2662-2671	relations	abstract[130]|event[131]	giv[130]|new[131]	_	_
22-9	2672-2675	are	_	_	_	_
22-10	2676-2680	also	_	_	_	_
22-11	2681-2690	necessary	_	_	_	_
22-12	2691-2693	in	_	_	_	_
22-13	2694-2699	order	_	_	_	_
22-14	2700-2702	to	_	_	_	_
22-15	2703-2712	delineate	_	_	_	_
22-16	2713-2721	acquired	_	_	_	_
22-17	2722-2725	and	_	_	_	_
22-18	2726-2734	lifelong	abstract[132]	giv[132]	coref	23-25[0_132]
22-19	2735-2737	PE	abstract[132]	giv[132]	_	_
22-20	2738-2739	.	_	_	_	_

#Text=Degree of ejaculatory control as well as degree of patient and partner distress should also be ascertained in order to fulfil a diagnosis of PE .
23-1	2740-2746	Degree	abstract[133]	new[133]	_	_
23-2	2747-2749	of	abstract[133]	new[133]	_	_
23-3	2750-2761	ejaculatory	abstract[133]|place|abstract[135]	new[133]|giv|giv[135]	_	_
23-4	2762-2769	control	abstract[133]|abstract[135]	new[133]|giv[135]	_	_
23-5	2770-2772	as	_	_	_	_
23-6	2773-2777	well	_	_	_	_
23-7	2778-2780	as	_	_	_	_
23-8	2781-2787	degree	abstract[136]	new[136]	_	_
23-9	2788-2790	of	abstract[136]	new[136]	_	_
23-10	2791-2798	patient	abstract[136]|person	new[136]|giv	coref	25-4
23-11	2799-2802	and	abstract[136]	new[136]	_	_
23-12	2803-2810	partner	abstract[136]|person|abstract[139]	new[136]|new|new[139]	coref|coref	34-21[228_139]|34-21[228_139]
23-13	2811-2819	distress	abstract[136]|abstract[139]	new[136]|new[139]	_	_
23-14	2820-2826	should	_	_	_	_
23-15	2827-2831	also	_	_	_	_
23-16	2832-2834	be	_	_	_	_
23-17	2835-2846	ascertained	_	_	_	_
23-18	2847-2849	in	_	_	_	_
23-19	2850-2855	order	_	_	_	_
23-20	2856-2858	to	_	_	_	_
23-21	2859-2865	fulfil	_	_	_	_
23-22	2866-2867	a	abstract[140]	giv[140]	_	_
23-23	2868-2877	diagnosis	abstract[140]	giv[140]	_	_
23-24	2878-2880	of	abstract[140]	giv[140]	_	_
23-25	2881-2883	PE	abstract[140]|abstract	giv[140]|giv	coref	24-20[146_0]
23-26	2884-2885	.	_	_	_	_

#Text=A psychological history is also important in order to assess the likelihood of a psychological cause or association with the PE .
24-1	2886-2887	A	abstract[142]	giv[142]	_	_
24-2	2888-2901	psychological	abstract[142]	giv[142]	_	_
24-3	2902-2909	history	abstract[142]	giv[142]	_	_
24-4	2910-2912	is	_	_	_	_
24-5	2913-2917	also	_	_	_	_
24-6	2918-2927	important	_	_	_	_
24-7	2928-2930	in	_	_	_	_
24-8	2931-2936	order	_	_	_	_
24-9	2937-2939	to	_	_	_	_
24-10	2940-2946	assess	_	_	_	_
24-11	2947-2950	the	abstract[143]	new[143]	_	_
24-12	2951-2961	likelihood	abstract[143]	new[143]	_	_
24-13	2962-2964	of	abstract[143]	new[143]	_	_
24-14	2965-2966	a	abstract[143]|abstract[144]	new[143]|new[144]	_	_
24-15	2967-2980	psychological	abstract[143]|abstract[144]	new[143]|new[144]	_	_
24-16	2981-2986	cause	abstract[143]|abstract[144]	new[143]|new[144]	_	_
24-17	2987-2989	or	abstract[143]	new[143]	_	_
24-18	2990-3001	association	abstract[143]|abstract[145]	new[143]|new[145]	_	_
24-19	3002-3006	with	abstract[143]|abstract[145]	new[143]|new[145]	_	_
24-20	3007-3010	the	abstract[143]|abstract[145]|abstract[146]	new[143]|new[145]|giv[146]	ana	25-1[0_146]
24-21	3011-3013	PE	abstract[143]|abstract[145]|abstract[146]	new[143]|new[145]|giv[146]	_	_
24-22	3014-3015	.	_	_	_	_

#Text=This includes identifying patient stressors , as well as assessing a history/presence of anxiety or depression .
25-1	3016-3020	This	abstract	giv	coref	26-12
25-2	3021-3029	includes	_	_	_	_
25-3	3030-3041	identifying	_	_	_	_
25-4	3042-3049	patient	person|abstract[149]	giv|new[149]	coref|coref	30-7|30-7
25-5	3050-3059	stressors	abstract[149]	new[149]	_	_
25-6	3060-3061	,	_	_	_	_
25-7	3062-3064	as	_	_	_	_
25-8	3065-3069	well	_	_	_	_
25-9	3070-3072	as	_	_	_	_
25-10	3073-3082	assessing	_	_	_	_
25-11	3083-3084	a	abstract[150]	new[150]	_	_
25-12	3085-3101	history/presence	abstract[150]	new[150]	_	_
25-13	3102-3104	of	abstract[150]	new[150]	_	_
25-14	3105-3112	anxiety	abstract[150]|abstract	new[150]|new	_	_
25-15	3113-3115	or	abstract[150]	new[150]	_	_
25-16	3116-3126	depression	abstract[150]|abstract	new[150]|new	_	_
25-17	3127-3128	.	_	_	_	_

#Text=A focused physical examination can point towards an underlying cause of PE and this may include a genitourinary examination and neurological assessment of the lower limbs .
26-1	3129-3130	A	event[153]	new[153]	coref	26-17[157_153]
26-2	3131-3138	focused	event[153]	new[153]	_	_
26-3	3139-3147	physical	event[153]	new[153]	_	_
26-4	3148-3159	examination	event[153]	new[153]	_	_
26-5	3160-3163	can	_	_	_	_
26-6	3164-3169	point	_	_	_	_
26-7	3170-3177	towards	_	_	_	_
26-8	3178-3180	an	abstract[154]	new[154]	_	_
26-9	3181-3191	underlying	abstract[154]	new[154]	_	_
26-10	3192-3197	cause	abstract[154]	new[154]	_	_
26-11	3198-3200	of	abstract[154]	new[154]	_	_
26-12	3201-3203	PE	abstract[154]|abstract	new[154]|giv	ana	26-14
26-13	3204-3207	and	_	_	_	_
26-14	3208-3212	this	abstract	giv	coref	29-14[177_0]
26-15	3213-3216	may	_	_	_	_
26-16	3217-3224	include	_	_	_	_
26-17	3225-3226	a	event[157]	giv[157]	_	_
26-18	3227-3240	genitourinary	event[157]	giv[157]	_	_
26-19	3241-3252	examination	event[157]	giv[157]	_	_
26-20	3253-3256	and	_	_	_	_
26-21	3257-3269	neurological	abstract[158]	new[158]	_	_
26-22	3270-3280	assessment	abstract[158]	new[158]	_	_
26-23	3281-3283	of	abstract[158]	new[158]	_	_
26-24	3284-3287	the	abstract[158]|object[159]	new[158]|new[159]	_	_
26-25	3288-3293	lower	abstract[158]|object[159]	new[158]|new[159]	_	_
26-26	3294-3299	limbs	abstract[158]|object[159]	new[158]|new[159]	_	_
26-27	3300-3301	.	_	_	_	_

#Text=A common diagnostic tool used in the assessment of premature ejaculation is the premature ejaculation diagnostic tool ( PEDT ) developed by Symonds et al. .
27-1	3302-3303	A	object[160]	new[160]	coref	27-13[164_160]
27-2	3304-3310	common	object[160]	new[160]	_	_
27-3	3311-3321	diagnostic	object[160]	new[160]	_	_
27-4	3322-3326	tool	object[160]	new[160]	_	_
27-5	3327-3331	used	_	_	_	_
27-6	3332-3334	in	_	_	_	_
27-7	3335-3338	the	abstract[161]	giv[161]	_	_
27-8	3339-3349	assessment	abstract[161]	giv[161]	_	_
27-9	3350-3352	of	abstract[161]	giv[161]	_	_
27-10	3353-3362	premature	abstract[161]|abstract[162]	giv[161]|giv[162]	coref	27-15[0_162]
27-11	3363-3374	ejaculation	abstract[161]|abstract[162]	giv[161]|giv[162]	_	_
27-12	3375-3377	is	_	_	_	_
27-13	3378-3381	the	object[164]	giv[164]	appos	27-19[0_164]
27-14	3382-3391	premature	object[164]	giv[164]	_	_
27-15	3392-3403	ejaculation	abstract|object[164]	giv|giv[164]	coref	28-10[171_0]
27-16	3404-3414	diagnostic	object[164]	giv[164]	_	_
27-17	3415-3419	tool	object[164]	giv[164]	_	_
27-18	3420-3421	(	_	_	_	_
27-19	3422-3426	PEDT	object	giv	coref	28-1[167_0]
27-20	3427-3428	)	_	_	_	_
27-21	3429-3438	developed	_	_	_	_
27-22	3439-3441	by	_	_	_	_
27-23	3442-3449	Symonds	person	new	_	_
27-24	3450-3452	et	_	_	_	_
27-25	3453-3456	al.	_	_	_	_
27-26	3457-3458	.	_	_	_	_

#Text=The tool asks questions regarding the ISSM criteria of premature ejaculation to cover all three components of the definition .
28-1	3459-3462	The	object[167]	giv[167]	coref	29-8[176_167]
28-2	3463-3467	tool	object[167]	giv[167]	_	_
28-3	3468-3472	asks	_	_	_	_
28-4	3473-3482	questions	abstract	new	_	_
28-5	3483-3492	regarding	_	_	_	_
28-6	3493-3496	the	abstract[170]	new[170]	_	_
28-7	3497-3501	ISSM	abstract|abstract[170]	new|new[170]	_	_
28-8	3502-3510	criteria	abstract[170]	new[170]	_	_
28-9	3511-3513	of	abstract[170]	new[170]	_	_
28-10	3514-3523	premature	abstract[170]|abstract[171]	new[170]|giv[171]	coref	34-12[0_171]
28-11	3524-3535	ejaculation	abstract[170]|abstract[171]	new[170]|giv[171]	_	_
28-12	3536-3538	to	_	_	_	_
28-13	3539-3544	cover	_	_	_	_
28-14	3545-3548	all	abstract[172]	giv[172]	_	_
28-15	3549-3554	three	abstract[172]	giv[172]	_	_
28-16	3555-3565	components	abstract[172]	giv[172]	_	_
28-17	3566-3568	of	abstract[172]	giv[172]	_	_
28-18	3569-3572	the	abstract[172]|abstract[173]	giv[172]|new[173]	_	_
28-19	3573-3583	definition	abstract[172]|abstract[173]	giv[172]|new[173]	_	_
28-20	3584-3585	.	_	_	_	_

#Text=It is important to note however that the tool fails to distinguish between acquired and lifelong PE , and as such , involvement by the clinician is important in the identification of the correct PE subtype .
29-1	3586-3588	It	abstract	new	cata	29-1[0_175]
29-2	3589-3591	is	_	_	_	_
29-3	3592-3601	important	_	_	_	_
29-4	3602-3604	to	abstract[175]	new[175]	_	_
29-5	3605-3609	note	abstract[175]	new[175]	_	_
29-6	3610-3617	however	abstract[175]	new[175]	_	_
29-7	3618-3622	that	abstract[175]	new[175]	_	_
29-8	3623-3626	the	abstract[175]|object[176]	new[175]|giv[176]	_	_
29-9	3627-3631	tool	abstract[175]|object[176]	new[175]|giv[176]	_	_
29-10	3632-3637	fails	abstract[175]	new[175]	_	_
29-11	3638-3640	to	abstract[175]	new[175]	_	_
29-12	3641-3652	distinguish	abstract[175]	new[175]	_	_
29-13	3653-3660	between	_	_	_	_
29-14	3661-3669	acquired	abstract[177]	giv[177]	coref	29-35[0_177]
29-15	3670-3673	and	abstract[177]	giv[177]	_	_
29-16	3674-3682	lifelong	abstract[177]	giv[177]	_	_
29-17	3683-3685	PE	abstract[177]	giv[177]	_	_
29-18	3686-3687	,	_	_	_	_
29-19	3688-3691	and	_	_	_	_
29-20	3692-3694	as	_	_	_	_
29-21	3695-3699	such	_	_	_	_
29-22	3700-3701	,	_	_	_	_
29-23	3702-3713	involvement	abstract[178]	new[178]	_	_
29-24	3714-3716	by	abstract[178]	new[178]	_	_
29-25	3717-3720	the	abstract[178]|person[179]	new[178]|giv[179]	_	_
29-26	3721-3730	clinician	abstract[178]|person[179]	new[178]|giv[179]	_	_
29-27	3731-3733	is	_	_	_	_
29-28	3734-3743	important	_	_	_	_
29-29	3744-3746	in	_	_	_	_
29-30	3747-3750	the	event[180]	new[180]	_	_
29-31	3751-3765	identification	event[180]	new[180]	_	_
29-32	3766-3768	of	event[180]	new[180]	_	_
29-33	3769-3772	the	event[180]|abstract[182]	new[180]|new[182]	_	_
29-34	3773-3780	correct	event[180]|abstract[182]	new[180]|new[182]	_	_
29-35	3781-3783	PE	event[180]|abstract|abstract[182]	new[180]|giv|new[182]	coref	30-13
29-36	3784-3791	subtype	event[180]|abstract[182]	new[180]|new[182]	_	_
29-37	3792-3793	.	_	_	_	_

#Text=It is also crucial to manage patient expectations when assessing patients with PE . Waldinger et al. found IELT to vary in a population of men with partners >6 months from 0.55 – 44.1 min , with a median latency time of 5.4 min .
30-1	3794-3796	It	abstract	new	cata	30-1[0_184]
30-2	3797-3799	is	_	_	_	_
30-3	3800-3804	also	_	_	_	_
30-4	3805-3812	crucial	_	_	_	_
30-5	3813-3815	to	abstract[184]	new[184]	_	_
30-6	3816-3822	manage	abstract[184]	new[184]	_	_
30-7	3823-3830	patient	abstract[184]|person|abstract[186]	new[184]|giv|new[186]	coref|coref|coref|coref	31-25[208_186]|32-6|31-25[208_186]|32-6
30-8	3831-3843	expectations	abstract[184]|abstract[186]	new[184]|new[186]	_	_
30-9	3844-3848	when	_	_	_	_
30-10	3849-3858	assessing	_	_	_	_
30-11	3859-3867	patients	person[187]	giv[187]	coref	31-1[201_187]
30-12	3868-3872	with	person[187]	giv[187]	_	_
30-13	3873-3875	PE	person[187]|abstract	giv[187]|giv	coref	34-25
30-14	3876-3877	.	_	_	_	_
30-15	3878-3887	Waldinger	person	new	_	_
30-16	3888-3890	et	_	_	_	_
30-17	3891-3894	al.	_	_	_	_
30-18	3895-3900	found	_	_	_	_
30-19	3901-3905	IELT	abstract	giv	coref	31-10
30-20	3906-3908	to	_	_	_	_
30-21	3909-3913	vary	_	_	_	_
30-22	3914-3916	in	_	_	_	_
30-23	3917-3918	a	person[191]	new[191]	_	_
30-24	3919-3929	population	person[191]	new[191]	_	_
30-25	3930-3932	of	person[191]	new[191]	_	_
30-26	3933-3936	men	person[191]|person	new[191]|new	_	_
30-27	3937-3941	with	person[191]	new[191]	_	_
30-28	3942-3950	partners	person[191]|person[193]	new[191]|new[193]	coref	31-4[0_193]
30-29	3951-3953	>6	person[191]|person[193]|time[194]	new[191]|new[193]|new[194]	_	_
30-30	3954-3960	months	person[191]|person[193]|time[194]	new[191]|new[193]|new[194]	_	_
30-31	3961-3965	from	person[191]|person[193]	new[191]|new[193]	_	_
30-32	3966-3970	0.55	person[191]|person[193]|quantity[195]	new[191]|new[193]|new[195]	_	_
30-33	3971-3972	–	person[191]|person[193]|quantity[195]	new[191]|new[193]|new[195]	_	_
30-34	3973-3977	44.1	person[191]|person[193]|quantity[195]|quantity	new[191]|new[193]|new[195]|new	_	_
30-35	3978-3981	min	person[191]|person[193]|quantity[195]|quantity	new[191]|new[193]|new[195]|new	_	_
30-36	3982-3983	,	_	_	_	_
30-37	3984-3988	with	_	_	_	_
30-38	3989-3990	a	time[199]	new[199]	_	_
30-39	3991-3997	median	time[199]	new[199]	_	_
30-40	3998-4005	latency	event|time[199]	giv|new[199]	coref	31-19
30-41	4006-4010	time	time[199]	new[199]	_	_
30-42	4011-4013	of	time[199]	new[199]	_	_
30-43	4014-4017	5.4	time[199]|time[200]	new[199]|new[200]	_	_
30-44	4018-4021	min	time[199]|time[200]	new[199]|new[200]	_	_
30-45	4022-4023	.	_	_	_	_

#Text=Some patients and/or partners may have preconceived perceptions about IELT that are well in excess of this median latency time and may consequently have unrealistic expectations of what can be achieved with therapy .
31-1	4024-4028	Some	person[201]	giv[201]	_	_
31-2	4029-4037	patients	person[201]	giv[201]	_	_
31-3	4038-4044	and/or	person[201]	giv[201]	_	_
31-4	4045-4053	partners	person[201]|person	giv[201]|giv	_	_
31-5	4054-4057	may	_	_	_	_
31-6	4058-4062	have	_	_	_	_
31-7	4063-4075	preconceived	abstract[203]	new[203]	_	_
31-8	4076-4087	perceptions	abstract[203]	new[203]	_	_
31-9	4088-4093	about	abstract[203]	new[203]	_	_
31-10	4094-4098	IELT	abstract[203]|event	new[203]|giv	coref	34-7
31-11	4099-4103	that	_	_	_	_
31-12	4104-4107	are	_	_	_	_
31-13	4108-4112	well	abstract[205]	new[205]	_	_
31-14	4113-4115	in	abstract[205]	new[205]	_	_
31-15	4116-4122	excess	abstract[205]	new[205]	_	_
31-16	4123-4125	of	abstract[205]	new[205]	_	_
31-17	4126-4130	this	abstract[205]|time[207]	new[205]|new[207]	_	_
31-18	4131-4137	median	abstract[205]|time[207]	new[205]|new[207]	_	_
31-19	4138-4145	latency	abstract[205]|event|time[207]	new[205]|giv|new[207]	_	_
31-20	4146-4150	time	abstract[205]|time[207]	new[205]|new[207]	_	_
31-21	4151-4154	and	_	_	_	_
31-22	4155-4158	may	_	_	_	_
31-23	4159-4171	consequently	_	_	_	_
31-24	4172-4176	have	_	_	_	_
31-25	4177-4188	unrealistic	abstract[208]	giv[208]	coref	32-6[212_208]
31-26	4189-4201	expectations	abstract[208]	giv[208]	_	_
31-27	4202-4204	of	abstract[208]	giv[208]	_	_
31-28	4205-4209	what	abstract[208]	giv[208]	_	_
31-29	4210-4213	can	_	_	_	_
31-30	4214-4216	be	_	_	_	_
31-31	4217-4225	achieved	_	_	_	_
31-32	4226-4230	with	_	_	_	_
31-33	4231-4238	therapy	event	giv	ana	33-1
31-34	4239-4240	.	_	_	_	_

#Text=By gaining an understanding of patient expectations concerning therapeutic outcomes , initiating suitable treatment , or modifying current treatment , can be appropriately managed .
32-1	4241-4243	By	_	_	_	_
32-2	4244-4251	gaining	_	_	_	_
32-3	4252-4254	an	abstract[210]	new[210]	_	_
32-4	4255-4268	understanding	abstract[210]	new[210]	_	_
32-5	4269-4271	of	abstract[210]	new[210]	_	_
32-6	4272-4279	patient	abstract[210]|person|abstract[212]	new[210]|giv|giv[212]	coref|coref	33-11[219_0]|33-11[219_0]
32-7	4280-4292	expectations	abstract[210]|abstract[212]	new[210]|giv[212]	_	_
32-8	4293-4303	concerning	_	_	_	_
32-9	4304-4315	therapeutic	abstract[213]	new[213]	_	_
32-10	4316-4324	outcomes	abstract[213]	new[213]	_	_
32-11	4325-4326	,	_	_	_	_
32-12	4327-4337	initiating	_	_	_	_
32-13	4338-4346	suitable	abstract[214]	giv[214]	coref	32-18[215_214]
32-14	4347-4356	treatment	abstract[214]	giv[214]	_	_
32-15	4357-4358	,	_	_	_	_
32-16	4359-4361	or	_	_	_	_
32-17	4362-4371	modifying	_	_	_	_
32-18	4372-4379	current	abstract[215]	giv[215]	coref	33-8[0_215]
32-19	4380-4389	treatment	abstract[215]	giv[215]	_	_
32-20	4390-4391	,	_	_	_	_
32-21	4392-4395	can	_	_	_	_
32-22	4396-4398	be	_	_	_	_
32-23	4399-4412	appropriately	_	_	_	_
32-24	4413-4420	managed	_	_	_	_
32-25	4421-4422	.	_	_	_	_

#Text=This is best achieved by setting achievable treatment goals with the patient .
33-1	4423-4427	This	event	giv	_	_
33-2	4428-4430	is	_	_	_	_
33-3	4431-4435	best	_	_	_	_
33-4	4436-4444	achieved	_	_	_	_
33-5	4445-4447	by	_	_	_	_
33-6	4448-4455	setting	_	_	_	_
33-7	4456-4466	achievable	abstract[218]	new[218]	coref	34-3[222_218]
33-8	4467-4476	treatment	abstract|abstract[218]	giv|new[218]	coref	34-3
33-9	4477-4482	goals	abstract[218]	new[218]	_	_
33-10	4483-4487	with	_	_	_	_
33-11	4488-4491	the	person[219]	giv[219]	_	_
33-12	4492-4499	patient	person[219]	giv[219]	_	_
33-13	4500-4501	.	_	_	_	_

#Text=Examples of treatment goals include increasing IELT , increasing control over ejaculation , increasing satisfaction with sexual intercourse and decreasing personal distress related to PE .
34-1	4502-4510	Examples	abstract[220]	new[220]	_	_
34-2	4511-4513	of	abstract[220]	new[220]	_	_
34-3	4514-4523	treatment	abstract[220]|abstract|abstract[222]	new[220]|giv|giv[222]	_	_
34-4	4524-4529	goals	abstract[220]|abstract[222]	new[220]|giv[222]	_	_
34-5	4530-4537	include	_	_	_	_
34-6	4538-4548	increasing	_	_	_	_
34-7	4549-4553	IELT	abstract	giv	appos	34-9[224_0]
34-8	4554-4555	,	_	_	_	_
34-9	4556-4566	increasing	abstract[224]	giv[224]	_	_
34-10	4567-4574	control	abstract[224]	giv[224]	_	_
34-11	4575-4579	over	abstract[224]	giv[224]	_	_
34-12	4580-4591	ejaculation	abstract[224]|abstract	giv[224]|giv	_	_
34-13	4592-4593	,	_	_	_	_
34-14	4594-4604	increasing	_	_	_	_
34-15	4605-4617	satisfaction	abstract[226]	new[226]	_	_
34-16	4618-4622	with	abstract[226]	new[226]	_	_
34-17	4623-4629	sexual	abstract[226]|event[227]	new[226]|new[227]	_	_
34-18	4630-4641	intercourse	abstract[226]|event[227]	new[226]|new[227]	_	_
34-19	4642-4645	and	_	_	_	_
34-20	4646-4656	decreasing	_	_	_	_
34-21	4657-4665	personal	abstract[228]	giv[228]	_	_
34-22	4666-4674	distress	abstract[228]	giv[228]	_	_
34-23	4675-4682	related	_	_	_	_
34-24	4683-4685	to	_	_	_	_
34-25	4686-4688	PE	abstract	giv	_	_
34-26	4689-4690	.	_	_	_	_
